Unilateral Ptosis in a Child with Wilm’s Tumor Induced by Vincristine
Aziza El Ouali, Karim Lahrache, Zohair El Haddar, Ayad Ghannam, Abdeladim Babakhouya, Maria Rkain, Noufissa Benajiba
Abstract
Open-access reader
Aziza El Ouali, Karim Lahrache, Zohair El Haddar, Ayad Ghannam, Abdeladim Babakhouya, Maria Rkain, Noufissa Benajiba
Abstract
Open-access reader
Vincristine is a chemotherapy drug belonging to the group of Vinca alkaloids which also includes vinblastine and vindesine. It is used in hematological malignancies and solid tumors. The Vinca alkaloids are neurotoxic, usually causing peripheral neuropathy, and rarely cranial neuropathies. We report a case of a 33-month-old male child diagnosed with Wilms’ tumor, who had an isolated unilateral right ptosis following vincristine, with a good improvement after stopping it.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Vincristine is a chemotherapy drug belonging to the group of Vinca alkaloids which also includes vinblastine and vindesine. It is used in hematological malignancies and solid tumors. The Vinca alkaloids are neurotoxic, usually causing peripheral neuropathy, and rarely cranial neuropathies. We report a case of a 33-month-old male child diagnosed with Wilms’ tumor, who had an isolated unilateral right ptosis following vincristine, with a good improvement after stopping it.
Key concepts: Vinca, Vindesine, Vincristine, Vinblastine, Ptosis, Medicine, Chemotherapy, Surgery